Y
YB Peptide
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A | 6 | 7.7 | 6.0 | 8.5 | 21 Aug 2025 |
| BPC-157 | E | 4 | 5.8 | 0.0 | 7.9 | 10 Sep 2025 |
| 17a-Methyl-1-Testosterone | X | 1 | 5.1 | 5.1 | 5.1 | 25 Apr 2025 |
| Anavar (Oxandrolone) | X | 1 | 4.7 | 4.7 | 4.7 | 27 Feb 2025 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X | 1 | 7.3 | 7.3 | 7.3 | 2 Apr 2025 |
| Botulinum toxin | X | 1 | 6.1 | 6.1 | 6.1 | 2 Jul 2025 |
| BPC157 10mg + TB500 10mg Blend | X | 1 | 8.8 | 8.8 | 8.8 | 20 Jun 2025 |
| Cardiogen | X | 1 | 9.3 | 9.3 | 9.3 | 6 May 2025 |
| Chonluten | X | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| CJC-1295 With DAC | X | 1 | 6.1 | 6.1 | 6.1 | 17 Dec 2024 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X | 1 | 4.4 | 4.4 | 4.4 | 14 Jan 2025 |
| DHB (1-Test Cyp) Oral | X | 1 | 5.0 | 5.0 | 5.0 | 7 May 2025 |
| Epithalon | X | 1 | 9.2 | 9.2 | 9.2 | 3 Jun 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X | 1 | 4.5 | 4.5 | 4.5 | 14 Jan 2025 |
| HCG | X | 1 | 6.2 | 6.2 | 6.2 | 8 Jul 2025 |
| HMG | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 |
| Hyaluronic acid | X | 1 | 5.5 | 5.5 | 5.5 | 2 Apr 2025 |
| KPV | X | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 |
| Livagen | X | 1 | 5.4 | 5.4 | 5.4 | 28 Mar 2025 |
| Minoxidil Oral | X | 1 | 6.4 | 6.4 | 6.4 | 11 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X | 1 | 5.4 | 5.4 | 5.4 | 7 May 2025 |
| NAD+ | X | 1 | 4.4 | 4.4 | 4.4 | 17 Dec 2024 |
| PE 22-28 | X | 1 | 4.5 | 4.5 | 4.5 | 25 Apr 2025 |
| PEG MGF | X | 1 | 7.8 | 7.8 | 7.8 | 2 Apr 2025 |
| Phenylacetic acid CAS 103-82-2 | X | 1 | 5.9 | 5.9 | 5.9 | 16 Mar 2025 |
| Prostamax | X | 1 | 6.9 | 6.9 | 6.9 | 17 Dec 2024 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X | 1 | 8.0 | 8.0 | 8.0 | 14 Jan 2025 |
| Retatrutide 30mg Pen Kit | X | 1 | 7.3 | 7.3 | 7.3 | 2 Jul 2025 |
| Selank 10mg + Semax 10mg Blend | X | 1 | 6.5 | 6.5 | 6.5 | 3 Jun 2025 |
| Telmisartan | X | 1 | 6.6 | 6.6 | 6.6 | 21 May 2025 |
| Testosterone Cypionate Raw | X | 1 | 8.3 | 8.3 | 8.3 | 13 Feb 2025 |
| TrenMix 200 | X | 1 | 6.9 | 6.9 | 6.9 | 16 Mar 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 24 May 2026 | TrenMix 200 | 5.7 | 200mg/ml | 191.8mg/ml | -4.1% | 99.13% | Lab B |
| 24 May 2026 | Cardiogen | 10.0 | 5mg | 4.7mg | -5.3% | 99.45% | Lab A |
| 24 May 2026 | Chonluten | 7.9 | 20mg | 21.7mg | +8.5% | 96.04% | Lab B |
| 24 May 2026 | HMG | 8.4 | 15mg | 14.0mg | -6.9% | 97.46% | Lab E |
| 23 May 2026 | DHB (1-Test Cyp) Oral | 7.3 | 50mg | 58.3mg | +16.7% | 98.59% | Lab F |
| 23 May 2026 | Phenylacetic acid CAS 103-82-2 | 6.0 | 10g | 8.9g | -11.3% | 95.30% | Lab G |
| 23 May 2026 | Selank 10mg + Semax 10mg Blend | 6.4 | 30mg | 32.8mg | +9.4% | 99.19% | Lab G |
| 23 May 2026 | Telmisartan | 8.8 | 10mg | 9.0mg | -9.9% | 97.32% | Lab D |
| 21 May 2026 | Livagen | 5.3 | 20mg | 24.7mg | +23.3% | 98.76% | Lab B |
| 19 May 2026 | Retatrutide | 6.0 | 5mg | 5.4mg | +8.0% | 99.50% | Lab G |
| 19 May 2026 | Prostamax | 5.5 | 50mg | 43.7mg | -12.6% | 99.02% | Lab E |
| 17 May 2026 | Anavar (Oxandrolone) | 4.1 | 20mg | 24.9mg | +24.7% | 97.31% | Lab B |
| 17 May 2026 | Epithalon | 10.0 | 15mg | 15.4mg | +2.6% | 98.35% | Lab B |
| 17 May 2026 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 7.5 | 250mg/ml | 234.0mg/ml | -6.4% | 96.22% | Lab A |
| 29 Jan 2026 | Botulinum toxin | 5.8 | 20mg | 22.0mg | +9.9% | 95.59% | Lab B |
| 29 Jan 2026 | Hyaluronic acid | 4.1 | 5mg | 4.7mg | -7.0% | 97.78% | Lab A |
| 26 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.3 | 10mg | 11.2mg | +11.7% | 95.39% | Lab G |
| 7 Jan 2026 | Testosterone Cypionate Raw | 7.5 | 10g | 12.2g | +21.7% | 98.93% | Lab B |
| 6 Jan 2026 | KPV | 5.7 | 20mg | 18.4mg | -8.1% | 95.98% | Lab F |
| 6 Jan 2026 | NAD+ | 4.4 | 20mg | 17.6mg | -11.9% | 96.58% | Lab A |
| 6 Jan 2026 | PE 22-28 | 4.8 | 50mg | 52.7mg | +5.5% | 95.07% | Lab A |
| 29 Dec 2025 | Retatrutide | 8.5 | 20mg | 21.6mg | +8.0% | 99.70% | Lab G |
| 29 Dec 2025 | Minoxidil Oral | 6.5 | 100mg | 102.3mg | +2.3% | 95.25% | Lab C |
| 23 Dec 2025 | BPC-157 | 7.6 | 10mg | 10.4mg | +4.0% | 99.72% | Lab E |
| 5 Dec 2025 | CJC-1295 With DAC | 4.5 | 2mg | 2.2mg | +11.2% | 96.55% | Lab A |
| 25 Nov 2025 | BPC-157 | 0.0 | 10mg | ⚠️ Sample does not contain BPC-157 ? | (no batch ID) | No Label / Silver Crimp / Violet Cap | |
| 25 Nov 2025 | Retatrutide | 8.0 | 10mg | 9.85mg | -1.5% | 99.95% | Lab E |
| 23 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.0 | 2mg | 2.3mg | +14.1% | 98.56% | Lab A |
| 23 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.0 | 15mg | 17.8mg | +18.9% | 99.44% | Lab G |
| 22 Nov 2025 | BPC-157 | 7.8 | 5mg | 5mg | 99.80% | Lab G | |
| 5 Nov 2025 | 17a-Methyl-1-Testosterone | 6.5 | 100mg | 98.0mg | -2.0% | 98.98% | Lab B |
| 5 Nov 2025 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 8.7 | 100g | 96.2g | -3.8% | 96.79% | Lab E |
| 5 Nov 2025 | PEG MGF | 6.9 | 30mg | 33.5mg | +11.6% | 97.41% | Lab C |
| 4 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 8.3 | 2mg | 1.7mg | -14.5% | 95.59% | Lab E |
| 17 Oct 2025 | Retatrutide 30mg Pen Kit | 7.2 | 50mg | 54.3mg | +8.7% | 98.27% | Lab A |
| 3 Oct 2025 | HCG | 4.8 | 20mg | 19.1mg | -4.5% | 99.08% | Lab C |
| 18 Sep 2025 | Retatrutide | 8.5 | 10mg | 9mg | -10.0% | 99.95% | Lab E |